Pfizer CEO ‌Albert ‌Bourla on Monday ​flagged issues with the leadership of ‌the ⁠U. Food and ⁠Drug Administration's vaccine ...

One of the most powerful voices in the biopharma industry, Pfizer CEO Albert Bourla, Ph.D., has weighed in with sharp ...

WASHINGTON -- The Biden administration purchased an additional 200 million doses of Pfizer-BioNTech's COVID-19 vaccine to prepare for potential additional vaccine needs in the US, an administration ...

Pfizer said today its COVID-19 vaccine has saved more than 14 million lives worldwide, after President Donald Trump urged pharmaceutical companies to justify the success of their pandemic drugs. In a ...

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...

A guide to coronavirus vaccination rollout and what you need to know about the authorized vaccines. Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna drugs ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

By Mariam Sunny March 2 (Reuters) - Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad, in response to a ...